Evidence map›Paper›PMID 38443695›Full record

ArticleNPJ precision oncology2024

An interpretable machine learning system for colorectal cancer diagnosis from pathology slides.

Pedro C Neto, Diana Montezuma, Sara P Oliveira, Domingos Oliveira, João Fraga, Ana Monteiro, João Monteiro, Liliana Ribeiro, Sofia Gonçalves, Stefan Reinhard and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in NPJ precision oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
16.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Pedro C Neto *Institute for Systems and Computer Engineering, Technology and Science (INESC TEC), R. Dr. Roberto Frias, Porto, 4200-465, Porto, Portugal. pedro.d.carneiro@inesctec.pt.ORCID http://orcid.org/0000-0003-1333-4889
Diana Montezuma *IMP Diagnostics, Praça do Bom Sucesso, 61, sala 808, Porto, 4150-146, Porto, Portugal. diana.felizardo@impdiagnostics.com.ORCID http://orcid.org/0000-0001-9551-4589
Sara P Oliveira *Institute for Systems and Computer Engineering, Technology and Science (INESC TEC), R. Dr. Roberto Frias, Porto, 4200-465, Porto, Portugal. s.oliveira@nki.nl.ORCID http://orcid.org/0000-0002-6586-9079
Domingos OliveiraIMP Diagnostics, Praça do Bom Sucesso, 61, sala 808, Porto, 4150-146, Porto, Portugal.
João FragaDepartment of Pathology, IPO-Porto, R. Dr. António Bernardino de Almeida 865, Porto, 4200-072, Porto, Portugal.
Ana MonteiroIMP Diagnostics, Praça do Bom Sucesso, 61, sala 808, Porto, 4150-146, Porto, Portugal.
João MonteiroIMP Diagnostics, Praça do Bom Sucesso, 61, sala 808, Porto, 4150-146, Porto, Portugal.
Liliana RibeiroIMP Diagnostics, Praça do Bom Sucesso, 61, sala 808, Porto, 4150-146, Porto, Portugal.ORCID http://orcid.org/0009-0009-5414-6906
Sofia GonçalvesIMP Diagnostics, Praça do Bom Sucesso, 61, sala 808, Porto, 4150-146, Porto, Portugal.
Stefan ReinhardInstitute of Pathology, University of Bern, Uni Bern, Murtenstrasse 31, Bern, 3008, Bern, Switzerland.ORCID http://orcid.org/0000-0001-7272-7792
Inti ZlobecInstitute of Pathology, University of Bern, Uni Bern, Murtenstrasse 31, Bern, 3008, Bern, Switzerland.
Isabel M PintoIMP Diagnostics, Praça do Bom Sucesso, 61, sala 808, Porto, 4150-146, Porto, Portugal.
Jaime S CardosoInstitute for Systems and Computer Engineering, Technology and Science (INESC TEC), R. Dr. Roberto Frias, Porto, 4200-465, Porto, Portugal.ORCID http://orcid.org/0000-0002-3760-2473
Universidade do Porto · PTUniversity of Bern · CHIPO Porto · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considering the profound transformation affecting pathology practice, we aimed to develop a scalable artificial intelligence (AI) system to diagnose colorectal cancer from whole-slide images (WSI). For this, we propose a deep learning (DL) system that learns from weak labels, a sampling strategy that reduces the number of training samples by a factor of six without compromising performance, an approach to leverage a small subset of fully annotated samples, and a prototype with explainable predictions, active learning features and parallelisation. Noting some problems in the literature, this study is conducted with one of the largest WSI colorectal samples dataset with approximately 10,500 WSIs. Of these samples, 900 are testing samples. Furthermore, the robustness of the proposed method is assessed with two additional external datasets (TCGA and PAIP) and a dataset of samples collected directly from the proposed prototype. Our proposed method predicts, for the patch-based tiles, a class based on the severity of the dysplasia and uses that information to classify the whole slide. It is trained with an interpretable mixed-supervision scheme to leverage the domain knowledge introduced by pathologists through spatial annotations. The mixed-supervision scheme allowed for an intelligent sampling strategy effectively evaluated in several different scenarios without compromising the performance. On the internal dataset, the method shows an accuracy of 93.44% and a sensitivity between positive (low-grade and high-grade dysplasia) and non-neoplastic samples of 0.996. On the external test samples varied with TCGA being the most challenging dataset with an overall accuracy of 84.91% and a sensitivity of 0.996.

Identifiers

PMID38443695
PMCPMC10914836
OpenAlexW4392471890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.